Mark B. Skaletsky

Mark B. Skaletsky is a declared insider at 4 companies; the most frequent names are AMAG Pharmaceuticals Inc., Gyre Therapeutics, Inc. and Alkermes Inc. Between 8 March 2007 and 16 September 2011, the trades on record add up to 15 filings.

The open-market record consists of 6 sales worth €1.4M, with no purchase. Besides market trades, the filings include 1 share grant and 6 option exercises.

The record was last updated on 21 September 2011 with a transaction in Alkermes plc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.